Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy

Saved in:
Bibliographic Details
Main Authors: Madhan Krishnan, Shyamaladevi Babu
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Oral Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906024004874
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553695744983040
author Madhan Krishnan
Shyamaladevi Babu
author_facet Madhan Krishnan
Shyamaladevi Babu
author_sort Madhan Krishnan
collection DOAJ
format Article
id doaj-art-bac02dc946f74aaeaf0f46457da6f724
institution Kabale University
issn 2772-9060
language English
publishDate 2024-09-01
publisher Elsevier
record_format Article
series Oral Oncology Reports
spelling doaj-art-bac02dc946f74aaeaf0f46457da6f7242025-01-09T06:17:01ZengElsevierOral Oncology Reports2772-90602024-09-0111100641Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapyMadhan Krishnan0Shyamaladevi Babu1Corresponding author. Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamilnadu, India.; Faculty of Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu, 603103, IndiaFaculty of Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu, 603103, Indiahttp://www.sciencedirect.com/science/article/pii/S2772906024004874
spellingShingle Madhan Krishnan
Shyamaladevi Babu
Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy
Oral Oncology Reports
title Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy
title_full Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy
title_fullStr Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy
title_full_unstemmed Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy
title_short Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy
title_sort harnessing programmed death ligand 1 as a prognostic marker in oscc challenges and opportunities in the era of immunotherapy
url http://www.sciencedirect.com/science/article/pii/S2772906024004874
work_keys_str_mv AT madhankrishnan harnessingprogrammeddeathligand1asaprognosticmarkerinosccchallengesandopportunitiesintheeraofimmunotherapy
AT shyamaladevibabu harnessingprogrammeddeathligand1asaprognosticmarkerinosccchallengesandopportunitiesintheeraofimmunotherapy